Because LAM affects almost exclusively women of child­bearing age, physicians have thought that the hormone estrogen might be involved in the abnormal muscle cell growth that characterizes the disease, just as it is in the growth of smooth muscle in the uterus in a woman's child­bearing years. Although there is no evidence that there is a relationship between estrogen and LAM, the treatment of LAM has focused on reducing the production or effects of estrogen.
• Obtenez de l’aide Maladies de A–Z Lymphangioleiomyomatose (LAM) La lymphangiolé?omyomatose (LAM) est une maladie très rare qui cause la prolifération de cellules musculaires lisses, principalement dans les poumons.